Egyptian International Pharmaceutical Investments (CAI:PHAR) Other Long-Term Liabilities : E£55 Mil (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Egyptian International Pharmaceutical Investments Other Long-Term Liabilities?

Egyptian International Pharmaceutical Investments's other long-term liabilities for the quarter that ended in Dec. 2023 was E£55 Mil.

Egyptian International Pharmaceutical Investments's quarterly other long-term liabilities declined from Jun. 2023 (E£5,667 Mil) to Sep. 2023 (E£57 Mil) and declined from Sep. 2023 (E£57 Mil) to Dec. 2023 (E£55 Mil).

Egyptian International Pharmaceutical Investments's annual other long-term liabilities declined from Dec. 2021 (E£72 Mil) to Dec. 2022 (E£59 Mil) and declined from Dec. 2022 (E£59 Mil) to Dec. 2023 (E£55 Mil).

Egyptian International Pharmaceutical Investments Other Long-Term Liabilities Historical Data

The historical data trend for Egyptian International Pharmaceutical Investments's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egyptian International Pharmaceutical Investments Other Long-Term Liabilities Chart

Egyptian International Pharmaceutical Investments Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Egyptian International Pharmaceutical Investments Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Egyptian International Pharmaceutical Investments Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Egyptian International Pharmaceutical Investments Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Egyptian International Pharmaceutical Investments's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Egyptian International Pharmaceutical Investments (CAI:PHAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Egyptian International Pharmaceutical Investments (CAI:PHAR) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1st Industrial Zone B1, EIPICO, 10th of Ramadan, EGY

Website

http://www.eipico.com.eg

Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, non-traditional dosage forms including soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. It exports its products to Arab countries, African, Asian and East European Countries. Its products portfolio includes antibiotics, anesthetics, analgesics, antihypertensives, cholesterol-lowering medications, ophthalmic products, blood substitutes and restoratives, dermatological drugs and vitamins. Some of its products are Vasotec, Co-vasotec, Flumox, and Cefotax.